121 related articles for article (PubMed ID: 24373555)
1. Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial.
Magosso E; Ansari MA; Gopalan Y; Shuaib IL; Wong JW; Khan NA; Abu Bakar MR; Ng BH; Yuen KH
Nutr J; 2013 Dec; 12(1):166. PubMed ID: 24373555
[TBL] [Abstract][Full Text] [Related]
2. Effects of Silybum marianum, Pueraria lobate, combined with Salvia miltiorrhiza tablets on non-alcoholic fatty liver disease in adults: A triple-blind, randomized, placebo-controlled clinical trial.
Li BY; Xi Y; Liu YP; Wang D; Wang C; Chen CG; Fang XH; Li ZX; Chen YM
Clin Nutr ESPEN; 2024 Jun; 63():2-12. PubMed ID: 38879879
[TBL] [Abstract][Full Text] [Related]
3. Cognitive function improvement with astaxanthin and tocotrienol intake: a randomized, double-blind, placebo-controlled study.
Sekikawa T; Kizawa Y; Li Y; Takara T
J Clin Biochem Nutr; 2020 Nov; 67(3):307-316. PubMed ID: 33293773
[TBL] [Abstract][Full Text] [Related]
4. Clinical investigation of the protective effects of palm vitamin E tocotrienols on brain white matter.
Gopalan Y; Shuaib IL; Magosso E; Ansari MA; Abu Bakar MR; Wong JW; Khan NA; Liong WC; Sundram K; Ng BH; Karuthan C; Yuen KH
Stroke; 2014 May; 45(5):1422-8. PubMed ID: 24699052
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological potential of tocotrienols: a review.
Ahsan H; Ahad A; Iqbal J; Siddiqui WA
Nutr Metab (Lond); 2014; 11(1):52. PubMed ID: 25435896
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Obesity and Metabolic Complications by Gamma and Delta Tocotrienols.
Zhao L; Fang X; Marshall MR; Chung S
Molecules; 2016 Mar; 21(3):344. PubMed ID: 26978344
[TBL] [Abstract][Full Text] [Related]
7. Vitamin E therapy beyond cancer: Tocopherol versus tocotrienol.
Peh HY; Tan WS; Liao W; Wong WS
Pharmacol Ther; 2016 Jun; 162():152-69. PubMed ID: 26706242
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial.
Panahi Y; Kianpour P; Mohtashami R; Jafari R; Simental-Mendía LE; Sahebkar A
Drug Res (Stuttg); 2017 Apr; 67(4):244-251. PubMed ID: 28158893
[TBL] [Abstract][Full Text] [Related]
9. Conjugated linoleic acid improves glycemic response, lipid profile, and oxidative stress in obese patients with non-alcoholic fatty liver disease: a randomized controlled clinical trial.
Ebrahimi-Mameghani M; Jamali H; Mahdavi R; Kakaei F; Abedi R; Kabir-Mamdooh B
Croat Med J; 2016 Aug; 57(4):331-42. PubMed ID: 27586548
[TBL] [Abstract][Full Text] [Related]
10. Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease.
Heebøll S; Kreuzfeldt M; Hamilton-Dutoit S; Kjær Poulsen M; Stødkilde-Jørgensen H; Møller HJ; Jessen N; Thorsen K; Kristina Hellberg Y; Bønløkke Pedersen S; Grønbæk H
Scand J Gastroenterol; 2016; 51(4):456-64. PubMed ID: 26784973
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
Chen S; Zhao X; Ran L; Wan J; Wang X; Qin Y; Shu F; Gao Y; Yuan L; Zhang Q; Mi M
Dig Liver Dis; 2015 Mar; 47(3):226-32. PubMed ID: 25577300
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.
Faghihzadeh F; Adibi P; Rafiei R; Hekmatdoost A
Nutr Res; 2014 Oct; 34(10):837-43. PubMed ID: 25311610
[TBL] [Abstract][Full Text] [Related]
13. Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease--14 months follow up.
Celinski K; Konturek PC; Slomka M; Cichoz-Lach H; Brzozowski T; Konturek SJ; Korolczuk A
J Physiol Pharmacol; 2014 Feb; 65(1):75-82. PubMed ID: 24622832
[TBL] [Abstract][Full Text] [Related]
14. Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study.
Aller R; Izaola O; Gómez S; Tafur C; González G; Berroa E; Mora N; González JM; de Luis DA
Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3118-24. PubMed ID: 26367736
[TBL] [Abstract][Full Text] [Related]
15. Vitamin E: Emerging aspects and new directions.
Galli F; Azzi A; Birringer M; Cook-Mills JM; Eggersdorfer M; Frank J; Cruciani G; Lorkowski S; Özer NK
Free Radic Biol Med; 2017 Jan; 102():16-36. PubMed ID: 27816611
[TBL] [Abstract][Full Text] [Related]
16. A new formulation of Gamma Delta Tocotrienol has superior bioavailability compared to existing Tocotrienol-Rich Fraction in healthy human subjects.
Meganathan P; Jabir RS; Fuang HG; Bhoo-Pathy N; Choudhury RB; Taib NA; Nesaretnam K; Chik Z
Sci Rep; 2015 Sep; 5():13550. PubMed ID: 26323969
[TBL] [Abstract][Full Text] [Related]
17. Tocotrienol and cancer metastasis.
De Silva L; Chuah LH; Meganathan P; Fu JY
Biofactors; 2016; 42(2):149-62. PubMed ID: 26948691
[TBL] [Abstract][Full Text] [Related]
18. Radioprotective Efficacy of Gamma-Tocotrienol in Nonhuman Primates.
Singh VK; Kulkarni S; Fatanmi OO; Wise SY; Newman VL; Romaine PL; Hendrickson H; Gulani J; Ghosh SP; Kumar KS; Hauer-Jensen M
Radiat Res; 2016 Mar; 185(3):285-98. PubMed ID: 26930378
[TBL] [Abstract][Full Text] [Related]
19. Focus on Pivotal Role of Dietary Intake (Diet and Supplement) and Blood Levels of Tocopherols and Tocotrienols in Obtaining Successful Aging.
Rondanelli M; Faliva MA; Peroni G; Moncaglieri F; Infantino V; Naso M; Perna S
Int J Mol Sci; 2015 Sep; 16(10):23227-49. PubMed ID: 26404241
[TBL] [Abstract][Full Text] [Related]
20. Short-term effects of a combined nutraceutical of insulin-sensitivity, lipid level and indexes of liver steatosis: a double-blind, randomized, cross-over clinical trial.
Cicero AF; Rosticci M; Parini A; Morbini M; Urso R; Grandi E; Borghi C
Nutr J; 2015 Mar; 14():30. PubMed ID: 25886384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
